The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
A study published in The Lancet HIV today showed that while the rate of newly reported HIV cases in Europe remained steady in younger people between 2004 and 2015, it increased by 2% each year overall in older people. With around 30 000 newly diagnosed HIV infections reported each year over the last decade, the HIV epidemic remains a significant public health problem in the 31 countries of the European Union and European Economic Area (EU/EEA),
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
Up to 50 million people a year are estimated to have symptomatic influenza in EU/EEA countries and between 15 000 – 70 000 are estimated to die from influenza associated causes.
Since the last update by ECDC in its risk assessment of 11 June 2015, 18 new cases and one death in a previously reported case have been reported by South Korean authorities.
The continuum of HIV care is a framework that enables countries to monitor the effectiveness of their HIV response - from diagnosis towards viral suppression (which means that the virus is no longer detectable in the blood). This report provides a snapshot of the status of the continuum of care for the whole region as well as each of the 48 countries reporting at least some continuum data.
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union Conference and ECDC , HIV experts from across the European Union discussed how to reverse the HIV epidemic and how to prepare Europe to achieve the set target of ending AIDS by 2030.
A steep increase of human cases of avian influenza A(H7N9) has been reported since the beginning of December 2016 from China. At present, the most immediate threat to EU citizens is to those living or visiting influenza A(H7N9)-affected areas in China concludes the updated rapid risk assessment.
Chlamydia infection, campylobacteriosis, salmonellosis, gonorrhoea and tuberculosis were the most commonly reported notifiable infectious diseases in the EU and EEA in 2014.
In a large community study (Flu Watch), cohorts were prospectively studied across the UK during six periods (2006-2010) with the main aim to compare the burden and the severity of seasonal and pandemic influenza across different age groups over time.